Calcium channel blockers and clinical outcomes in patients with continuous-flow left ventricular assist devices

被引:0
作者
Tie, Hongtao [1 ,2 ]
Li, Zhenhan [3 ,4 ]
Welp, Henryk [1 ]
Guha, Avirup [5 ,6 ]
Caraballo, Cesar [7 ,8 ]
Deschka, Heinz [1 ]
Shi, Rui [9 ]
Zheng, Xiaoqing [10 ]
Martens, Sven [1 ]
Sindermann, Jurgen [1 ]
Chen, Dan [2 ]
Wu, Qingchen [2 ]
Martens, Sabrina [1 ]
机构
[1] Univ Hosp Muenster, Dept Cardiothorac Surg, Albert Schweitzer Campus 1, D-48149 Munster, Germany
[2] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Chongqing, Peoples R China
[3] Chongqing Tradit Chinese Med Hosp, Dept Endocrinol, Chongqing, Peoples R China
[4] Univ Hosp Muenster, Dept Anaesthesiol Intens Care Med & Pain Med, Munster, Germany
[5] Augusta Univ, Med Coll Georgia, Dept Internal Med, Div Cardiol, Augusta, GA USA
[6] Ohio State Univ, Med Ctr, Cardiooncol Program, Div Cardiol, Columbus, OH USA
[7] Yale Sch Med, Sect Cardiovasc Med, New Haven, CT USA
[8] Ctr Outcomes Res & Evaluat, New Haven, CT USA
[9] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Crit Care Med, Guangzhou, Peoples R China
[10] Univ Pittsburgh, Pittsburgh, PA USA
来源
ESC HEART FAILURE | 2024年 / 11卷 / 01期
关键词
Calcium channel blocker; LVAD; Survival; Adverse events; WORSENING RENAL-FUNCTION; CHRONIC HEART-FAILURE; EJECTION FRACTION; TRANSPLANTATION; ASSOCIATION; AMLODIPINE; SOCIETY; RISK;
D O I
10.1002/ehf2.14576
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsCurrent guidelines suggest calcium channel blockers (CCBs) as the second or third option for blood pressure management in patients with left ventricular assist device (LVAD). However, the clinical outcomes of patients with LVAD who receive CCBs remain unclear. Our study aims to analyse the association of CCBs with clinical outcomes in patients after LVAD implantation.Methods and resultsThis is a retrospective analysis based on the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) from 2006 to 2017, and adult patients who were alive with LVAD and CCB treatment information at 6 months after implantation were included. Among 10 717 patients, 1369 received CCBs 6 months after implantation, and there was an increasing trend of CCB use after LVAD. Patients receiving CCB therapy at 6 months had a similar 5 year survival rate to those not receiving CCB [49.6%, 95% confidence interval (CI): 47.5-51.7% vs. 51.1%, 95% CI: 45.3-56.7%]. In both Cox and competing risk regressions after adjusting for confounding factors, CCB treatment at 6 months after implantation was not associated with long-term mortality [hazard ratio (HR): 1.03, 95% CI: 0.91-1.17, P = 0.624 and subdistribution HR (SHR): 1.07, 95% CI: 0.95-1.22, P = 0.260]. Consistently, in time-varying models, CCB treatment was not linked to long-term mortality (HR: 0.97, 95% CI: 0.87-1.09, P = 0.682 and SHR: 1.05, 95% CI: 0.94-1.18, P = 0.359). This null association remained in subgroup analysis according to device strategy and propensity-matching analyses. Neurological dysfunction, stroke, bleeding, rehospitalization, and renal dysfunction were more likely to occur among those with CCB when compared with those without CCB treatment.ConclusionsIn patients with LVAD, CCB therapy fails to show benefits in long-term survival and is associated with increased incidences of neurological dysfunction, bleeding, renal dysfunction, and rehospitalization.
引用
收藏
页码:271 / 281
页数:11
相关论文
共 50 条
  • [21] Continuous-flow left ventricular assist devices: Management in the emergency department
    Hockstein, Maxwell A.
    JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN, 2020, 1 (04) : 362 - 370
  • [22] Clinical Outcomes After Continuous-Flow Left Ventricular Assist Device A Systematic Review
    McIlvennan, Colleen K.
    Magid, Kate H.
    Ambardekar, Amrut V.
    Thompson, Jocelyn S.
    Matlock, Daniel D.
    Allen, Larry A.
    CIRCULATION-HEART FAILURE, 2014, 7 (06) : 1003 - U237
  • [23] Outcomes After Infections in Adolescents and Young Adults with Continuous-Flow Left Ventricular Assist Devices
    Chen, Sharon
    Cantor, Ryan S.
    Auerbach, Scott
    Schumacher, Kurt
    Almond, Christopher S.
    Eghtesady, Pirooz
    Alejos, Juan
    Das, Bibhuti B.
    Hong, Borah J.
    Jaquiss, Robert D. B.
    Kirklin, James K.
    Jeewa, Aamir
    ASAIO JOURNAL, 2019, 65 (04) : 380 - 388
  • [24] Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation
    Vest, Amanda R.
    Mistak, Stanley M.
    Hachamovitch, Rory
    Mountis, Maria M.
    Moazami, Nader
    Young, James B.
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (10) : 789 - 796
  • [25] Outcomes of Adult Patients with Small Body Size Supported with a Continuous-Flow Left Ventricular Assist Device
    Lee, Sangjin
    Katz, Jason N.
    Jorde, Ulrich P.
    Moazami, Nader
    John, Ranjit
    Sundareswaran, Kartik S.
    Farrar, David J.
    Frazier, O. H.
    ASAIO JOURNAL, 2016, 62 (06) : 646 - 651
  • [26] Safety of Contemporary Heart Failure Therapy in Patients with Continuous-Flow Left Ventricular Assist Devices
    Schnettler, Jessica Kristin
    Roehrich, Luise
    Just, Isabell Anna
    Pergantis, Panagiotis
    Stein, Julia
    Mueller, Marcus
    Mulzer, Johanna
    Knierim, Jan
    Falk, Volkmar
    Potapov, F. Evgenij
    Schoenrath, Felix
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (12) : 1328 - 1336
  • [27] Stroke After Left Ventricular Assist Device Implantation: Outcomes in the Continuous-Flow Era
    Harvey, Laura
    Holley, Christopher
    Roy, Samit S.
    Eckman, Peter
    Cogswell, Rebecca
    Liao, Kenneth
    John, Ranjit
    ANNALS OF THORACIC SURGERY, 2015, 100 (02) : 535 - 541
  • [28] The Hemodynamic Effects of Aortic Insufficiency in Patients Supported With Continuous-Flow Left Ventricular Assist Devices
    Sayer, Gabriel
    Sarswat, Nitasha
    Kim, Gene H.
    Adatya, Sirtaz
    Medvedofsky, Diego
    Rodgers, Daniel
    Kruse, Eric
    Ota, Takeyoshi
    Jeevanandam, Valluvan
    Lang, Roberto
    Uriel, Nir
    JOURNAL OF CARDIAC FAILURE, 2017, 23 (07) : 545 - 551
  • [29] Hemodynamic and exercise performance with Pulsatile and continuous-flow left ventricular assist devices
    Haft, Jonathan
    Armstrong, William
    Dyke, David B.
    Aaronson, Keith D.
    Koelling, Todd M.
    Farrar, David J.
    Pagani, Francis D.
    CIRCULATION, 2007, 116 (11) : I8 - I15
  • [30] The Physiological Rationale for Incorporating Pulsatility in Continuous-Flow Left Ventricular Assist Devices
    Grosman-Rimon, Liza
    Billia, Filio
    Kobulnik, Jeremy
    Bar-Ziv, Stacey Pollock
    Cherney, David Z.
    Rao, Vivek
    CARDIOLOGY IN REVIEW, 2018, 26 (06) : 294 - 301